With an extensive background in the financial and biotechnology sectors, Aras co-founded Avicanna in Toronto with the goal of establishing a biopharmaceutical company focused on the medical and pharmaceutical applications of cannabinoids. His expertise in corporate development coupled with his executive experience in the oncology industry have been integral to Avicanna’s research and development and clinical advancement efforts. Since 2016, Aras has led a team of executives, scientists and medical professionals across several countries in developing quality controls, scientific advances and competitive advantages.
Aras Azadian
